Dare Bioscience
NASDAQ: DARESan Diego, US · Delaware corporation · 1 known investors
Daré Bioscience is a women's health biotech company that conducts end-to-end clinical development of targeted therapeutics and products for conditions across areas such as contraception, menopause, vaginal infections, and sexual wellness. It sells clinically-studied products including Sildenafil arousal cream and a vaginal microbiome probiotic through its DARE Health Hub pharmacy and telehealth service, serving women and OB/GYN providers nationwide in the US.
Founders & leadership
MH
MarDee Haring-LaytonChief Accounting Officer
SM
Sabrina Martucci JohnsonFounder & Chief Executive Officer
CD
Christopher D.T. GuiffreExecutive
GB
Gregg BeloffExecutive
AV
Alejandra V. CarvajalExecutive
AS
Adrian SenderowiczExecutive
JD
Jessica D. GrossmanNamed on SEC filing
RJ
Robin J. SteeleNamed on SEC filing
Board
AL
JG
Jessica GrossmanBoard director
WH
William H. RastetterBoard director
RS
Robin SteeleBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$38.3M disclosed across 5 of 6 rounds · 2016–2026
▶$12.4MraisedAug 2026 · 12 investors · BiotechnologyRule 506(b)
▶$12.4MraisedAug 2026 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sabrina Martucci JohnsonExecutive Officer, Director
- MarDee Haring-LaytonExecutive Officer
- William H. RastetterDirector
- Jessica D. GrossmanDirector
- Susan L. KelleyDirector
- Gregory W. MatzDirector
- Robin J. SteeleDirector
- Offering amount
- $12.4M
- Amount sold
- $12.4M
- Placement agents
- Ladenburg Thalmann & Co. Inc.
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MofferedNov 2024 · 1 investors · BiotechnologyRule 506(b)
▶$15MofferedNov 2024 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- MarDee Haring-LaytonExecutive Officer
- Jessica GrossmanDirector
- William H. RastetterDirector
- Robin SteeleDirector
- Susan L. KelleyDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Gregory W. MatzDirector
- Offering amount
- $15M
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Sophia N. Ononye-OnyiaDirector
- Jessica D. GrossmanDirector
- Cheryl R. BlanchardDirector
- Susan L. KelleyDirector
- Robin J. SteeleDirector
- Lisa Walters-HoffertExecutive Officer
- William H. RastetterDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Gregory W. MatzDirector
- Offering amount
- $4.2M
- Amount sold
- $1.7M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.5MraisedSep 2021 · 28 investors · BiotechnologyRule 506(b)
▶$3.5MraisedSep 2021 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin J. SteeleDirector
- Susan L. KelleyDirector
- Lisa Walters-HoffertExecutive Officer
- Jessica D. GrossmanDirector
- Cheryl BlanchardDirector
- William H. RastetterDirector
- Gregory W. MatzDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Nov 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20.7MraisedJul 2017 · 18 investors · BiotechnologyRule 506(b)
▶$20.7MraisedJul 2017 · 18 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robin J. SteeleDirector
- Lisa Walters-HoffertExecutive Officer
- Roger L. HawleyDirector
- William H. RastetterDirector
- Susan L. KelleyDirector
- Sabrina Martucci JohnsonExecutive Officer, Director
- Offering amount
- $20.7M
- Amount sold
- $20.7M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1raisedOct 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$1raisedOct 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christopher D.T. GuiffreExecutive Officer, Director
- Gregg BeloffExecutive Officer
- Alejandra V. CarvajalExecutive Officer
- Adrian SenderowiczExecutive Officer
- David R. ParkinsonDirector
- William H. RastetterDirector
- William T. McKeeDirector
- Alan L. CraneDirector
- Susan L. KelleyDirector
- David WaltDirector
- Stuart A. ArbuckleDirector
- Paul A. FriedmanDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 6
by search overlap
Alloy77 shared keywordsAlloy is a telehealth service that connects women in midlife and menopause with board-certified, menopause-trained doctors for treatments including hormone therapy, GLP-1 weight care, skincare, sexual health, hair and gut health. It offers online intake, ongoing messaging with physicians, and cash-pay/FSA-HSA-eligible prescription products.
Vellabio73 shared keywordsVella Bioscience develops products for women's sexual and reproductive health using nano-encapsulated liposomal cannabidiol and liposome-based biotech to improve absorption of active ingredients, with a focus on female arousal, orgasm, and related pain. Its work spans the broader landscape of women's sexual and reproductive medicine.
Evernow58 shared keywordsEvernow provides virtual menopause care for women, offering one-time video visits and ongoing membership access to certified menopause providers who prescribe hormone therapy and estrogen replacement. It also sells medically curated supplements targeting menopause symptoms such as sleep, mood, energy, skin, and metabolism.
Hone57 shared keywordsHone is an online clinic offering telehealth consultations, doctor-prescribed medications, and biomarker testing to help aging men and women manage their health. It provides personalized, proactive care aimed at Americans seeking to improve health and longevity.
Walgreens57 shared keywordsWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
Midi Health55 shared keywordsMIDI develops digital health solutions for patients and clinicians to improve access to and delivery of care across diverse populations. The company takes an experimental approach to building tools that address unmet clinical needs.
Companies competing with Dare Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Dare Bioscience do?
- Daré Bioscience is a women's health biotech company that conducts end-to-end clinical development of targeted therapeutics and products for conditions across areas such as contraception, menopause, vaginal infections, and sexual wellness. It sells clinically-studied products including Sildenafil arousal cream and a vaginal microbiome probiotic through its DARE Health Hub pharmacy and telehealth service, serving women and OB/GYN providers nationwide in the US.
- Who are Dare Bioscience's investors?
- Dare Bioscience's investors include Polaris Partners.
- How much funding has Dare Bioscience raised?
- Dare Bioscience has disclosed $38.3M raised across 5 of its 6 known rounds.
- Where is Dare Bioscience headquartered?
- Dare Bioscience is headquartered in San Diego, US.